Predicting pulmonary complications after esophagectomy: A retrospective cohort study
Indian Journal of Cancer · 2025
DOI: 10.4103/ijc.ijc_67_22 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Indian Journal of Cancer, 2025. Verfasst von Priya Ranganathan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Tata Memorial Centre, Homi Bhabha National Institute, Ernest Borges Road, Parel, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Esophagectomy, Postoperative Complications, Lung Diseases, Esophageal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
Pulmonary complications are the main cause of postoperative mortality in patients undergoing esophagectomy. The aim of this study was to identify the risk factors associated with major pulmonary complications in these patients.
Methods
This was a retrospective cohort study of patients who underwent esophagectomy between January 2004 and December 2014. We retrieved data on patient- and surgery-related variables and the postoperative complications from medical records, including age, gender, physical status as per the American Society of Anesthesiologists’ (ASA) classification, smoking status, hemoglobin, albumin, creatinine, forced expiratory volume in the first second (FEV1), neoadjuvant therapy, type of surgery (transthoracic vs. others), thoracic approach (minimally invasive vs. open), lymphadenectomy type (three field or abdominal vs. two field), intraoperative blood loss, operative time, and use of epidural analgesia. We classified pulmonary complications using the Clavien–Dindo system. Multivariable logistic regression analysis was used to derive the odds ratios (OR) with 95% confidence intervals (CI) to identify significant risk factors for major pulmonary complications (Clavien–Dindo grade 3 or more).
Results
We obtained relevant data on 1189 patients operated during the study period. Increasing age (OR 1.03, 95% CI 1.01; 1.04; P < 0.01), FEV1% less than 70% (OR 1.71, 95% CI 1.03; 2.83; P = 0.04), three-field lymphadenectomy (OR 2.12, 95% CI 1.50; 3.01; P < 0.01), and use of analgesia techniques other than epidural (OR 1.51, 95% CI 1.07; 2.13; P = 0.02) were independent predictors of major pulmonary complications.
Conclusions
The recognition of factors associated with increased risk of pulmonary complications in patients undergoing esophagectomy could help in risk stratification, preoperative optimization, and early detection of complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anaesthesiology, Tata Memorial Centre, Homi Bhabha National Institute, Ernest Borges Road, Parel, Mumbai, Maharashtra, India.
- Department of Division of Thoracic Surgery, Department of Surgical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Ernest Borges Road, Parel, Mumbai, Maharashtra, India.
- Department of Thoracic Surgery, National Institute of Tuberculosis and Respiratory Diseases, Sri Aurobindo Marg, New Delhi, India.
Zitieren
APA
Ranganathan, P., Jiwnani, S., Ashok, A., Purwar, P., Karimundackal, G., Parab, S., Shetmahajan, M., & Pramesh, C. S. (2025). Predicting pulmonary complications after esophagectomy: A retrospective cohort study. Indian Journal of Cancer. https://doi.org/10.4103/ijc.ijc_67_22
Vancouver
Ranganathan P, Jiwnani S, Ashok A, Purwar P, Karimundackal G, Parab S, et al. Predicting pulmonary complications after esophagectomy: A retrospective cohort study. Indian Journal of Cancer. 2025. doi:10.4103/ijc.ijc_67_22
BibTeX
@article{Ranganathan2025,
author = {Ranganathan, Priya and Jiwnani, Sabita and Ashok, Apurva and Purwar, Pallavi and Karimundackal, George and Parab, Swapnil and Shetmahajan, Madhavi and Pramesh, Conjeevaram S},
title = {Predicting pulmonary complications after esophagectomy: A retrospective cohort study},
journal = {Indian Journal of Cancer},
year = {2025},
doi = {10.4103/ijc.ijc_67_22}
}
EUVIMED